Osteoarthritis
Conditions
Brief summary
Retrospective collection of data, aimed at a better knowledge of the context of use of Synvisc® among the patients practising a regular activity (professional/leisure), and at evaluating the different practices and their results.
Interventions
DRUGSynvisc®
Sponsors
Boehringer Ingelheim
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* use of Synvisc® * patients practising a regular activity (professional/leisure)
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Amount of medication consumed | up to 1 year | antalgics, non-steroid anti-inflammatory drugs (NSAIDs), steroid anti-inflammatory drugs (SAIDs) |
Secondary
| Measure | Time frame |
|---|---|
| Patient-assessed benefit on a 2-point verbal rating scale | up to 1 year |
Outcome results
None listed